Glenmark Pharmaceuticals informs about media release

21 Sep 2021 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release on 21st September 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1162.00 7.05 (0.61%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.